Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Fetal iodine syndrome refers to symptoms and signs that may be observed in a fetus or newborn when the mother was exposed during pregnancy to inappropriate (insufficient or excessive) amounts of iodine. Iodine deficiency is associated with goiter and hypothyroidism. When severe iodine deficiency occurs during pregnancy, it is associated with congenital hypothyroidism that is manifested by increased neonatal morbi-mortality and severe mental dysfunction, hyperactivity, attention disorders and a substantial decrease of IQ of an irreversible nature. Excessive iodine ingestion during the third trimester of pregnancy can result in hypothyroidism and fetal goiter due to a prolonged inhibition of thyroid hormone synthesis, an increase in thyrotropin (TSH).
Features include: Spastic diplegia, Hearing loss (hearing impairment), Congenital goiter, and Abnormality of metabolism/homeostasis and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Spastic diplegia, Intellectual disability |
Biomarker and diagnostic research for fetal iodine syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for fetal iodine syndrome.
181 publications have been identified in PubMed for fetal iodine syndrome. Research spans Review / Meta-Analysis (25%), Epidemiology / Natural History (24%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 46 | 25% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Congenital goiter, Congenital hypothyroidism |
Ears | 1 | Hearing loss (hearing impairment) |
Metabolism | 1 | Abnormality of metabolism/homeostasis |
Hormones | 1 | Congenital hypothyroidism |
43 |
24% |
Laboratory research | 36 | 20% |
Testing and diagnosis research | 23 | 13% |
Patient case studies | 18 | 10% |
Clinical study results | 10 | 6% |
New treatment approaches | 3 | 2% |
Other research | 2 | 1% |
Mohammed HO (2026). [PMID: 41928158](https://pubmed.ncbi.nlm.nih.gov/41928158/). *BMC Pediatr*. [Basic Science / Preclinical]
Young C (2026). [PMID: 41979536](https://pubmed.ncbi.nlm.nih.gov/41979536/). *FASEB J*. [Review / Meta-Analysis]
Givler DN (2026). [PMID: 28613785](https://pubmed.ncbi.nlm.nih.gov/28613785/). *Unknown Journal*. [Diagnostic / Biomarker]
Law LS (2026). [PMID: 41572575](https://pubmed.ncbi.nlm.nih.gov/41572575/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Tsuji M (2026). [PMID: 40451172](https://pubmed.ncbi.nlm.nih.gov/40451172/). *Dev Neurosci*. [Review / Meta-Analysis]
Khatri A (2026). [PMID: 41611636](https://pubmed.ncbi.nlm.nih.gov/41611636/). *Clin Endocrinol (Oxf)*. [Epidemiology / Natural History]
Dermitzaki N (2026). [PMID: 40976938](https://pubmed.ncbi.nlm.nih.gov/40976938/). *Acta paediatrica (Oslo, Norway : 1992)*. [Diagnostic / Biomarker]
Romitti M (2026). [PMID: 41974972](https://pubmed.ncbi.nlm.nih.gov/41974972/). *Nat Rev Endocrinol*. [Review / Meta-Analysis]
Nou-Fontanet L (2026). [PMID: 41552915](https://pubmed.ncbi.nlm.nih.gov/41552915/). *Movement disorders : official journal of the Movement Disorder Society*. [Epidemiology / Natural History]
Grošelj U (2026). [PMID: 41002024](https://pubmed.ncbi.nlm.nih.gov/41002024/). *J Perinat Med*. [Review / Meta-Analysis]